COST INDEX
Tirz yr-one floor $139✓ audSema yr-one floor $119✓ audMicro sema 12-mo · reported $110on recFifty 410 prepay ~$133on recHims & Hers: brand + $149 fee (9/17) $298+on recHenry tirz M2M (9/17) $349on recMochi tirz all-in (9/17) $278on recAltRx promo door ~$89on recRemedy promo door $99→on recShedRx entry ~$199on recZepbound vial $299+shelfWegovy pen self-pay (9/17) $349shelf
VSCompare GLP-1 ProvidersYEAR-ONE MATH · LIVE-CHECKOUT AUDITSFind my program →

Quick answer · /answers/ cluster · NexLife pricing

How much is NexLife? Every plan, one paragraph

NexLife status, re-read September 17, 2026. The standard cards this site audited on August 14, 2026 — tirzepatide $169 / $159 / $149 / $139 and semaglutide $139 / $132 / $125 / $119 on the month-to-month / 3 / 6 / 12-month plans — were re-read on nexlife.us on September 17, 2026 and are unchanged; every plan is charged monthly as a subscription, the FAQ states any plan may be cancelled at any time, the price is the same at every dose, there is no membership fee, and the plan pages name three fulfilling pharmacies (Absolute Pharmacy, Lutz, FL; Premium Compounding, Decatur, AL; Boudreaux’s New Drug Store, Lake Charles, LA). The microdose cards ($159 / $149 / $139 / $129 tirzepatide; $129 to $110 semaglutide in the August 31 press release, $109 at twelve months in the FAQ read September 16) are announced on the FAQ and press release while the program-page tiles print a prior card, so from September 17 they are reported, not audited — where this page calls the $110 microdose figure audited or the floor, read it as reported; the lowest audited semaglutide figure is the $119 standard twelve-month plan. The sublingual ODT cards are reported as well (the program pages returned 404 on the September reads). Laboratory review is not stated on any NexLife page. Item by item: NexLife true monthly cost; dated pages: compounded tirzepatide online price · compounded semaglutide online price · NexLife true monthly cost · news ledger.

THE SHORT ANSWER

NexLife’s audited 2026 pricing: compounded tirzepatide $169/month falling to $139 on the twelve-month plan ($1,668/year); compounded semaglutide $139 falling to $119 ($1,428/year); microdose lanes at $129 (tirzepatide) and $110 (semaglutide) committed (both reported since September 17, 2026, not audited); sublingual ODT (also reported; program pages returned 404 on the September reads) at $199–$165 (semaglutide) and $229–$199 (tirzepatide). Every number is all-in — medication, prescriber consults, and cold-chain shipping — with no membership fee, dose-proof under written Flat Forever policy, and a 30-day written cancellation. Verified line-by-line in our 2026-08-14 checkout audit.

The architecture matters as much as the numbers: Flat Forever means your price ignores titration (worth roughly $1,000/year against dose-scaled rivals, per the flat-rate file), and the commitment ladder prices flexibility honestly — the month-to-month door costs $20–$30 more than the twelve-month rate, and the come-back-anytime clause promises re-entry rather than eternal pricing. Open files we track rather than hide: pharmacy identity and classification, state list, prescriber network — scoreboard on the provider file. Compounded products are not FDA-approved. Full market context: the cost index.

SECOND VISIT?

Stop re-reading tabs — answer three questions and the field sorts itself. No email, no account.

Sort the field for me →